Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironment.

De Sanctis F, Sandri S, Ferrarini G, Pagliarello I, Sartoris S, Ugel S, Marigo I, Molon B, Bronte V.

Front Immunol. 2014 Feb 24;5:69. doi: 10.3389/fimmu.2014.00069. eCollection 2014. Review.

2.

From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors.

Draghiciu O, Nijman HW, Daemen T.

Clin Dev Immunol. 2011;2011:439053. doi: 10.1155/2011/439053. Epub 2011 Dec 8. Review.

3.

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice.

Lu T, Ramakrishnan R, Altiok S, Youn JI, Cheng P, Celis E, Pisarev V, Sherman S, Sporn MB, Gabrilovich D.

J Clin Invest. 2011 Oct;121(10):4015-29. doi: 10.1172/JCI45862. Epub 2011 Sep 12.

4.

Translational research involving oxidative stress and diseases of aging.

Floyd RA, Towner RA, He T, Hensley K, Maples KR.

Free Radic Biol Med. 2011 Sep 1;51(5):931-41. doi: 10.1016/j.freeradbiomed.2011.04.014. Epub 2011 Apr 14. Review.

5.

Nitric oxide: perspectives and emerging studies of a well known cytotoxin.

Paradise WA, Vesper BJ, Goel A, Waltonen JD, Altman KW, Haines GK, Radosevich JA.

Int J Mol Sci. 2010 Jul 16;11(7):2715-45. doi: 10.3390/ijms11072715. Review.

6.

Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma.

Wang Z, He W, Yang G, Wang J, Wang Z, Nesland JM, Holm R, Suo Z.

BMC Cancer. 2010 Jul 5;10:352. doi: 10.1186/1471-2407-10-352.

7.

Myeloid-derived suppressor cells as regulators of the immune system.

Gabrilovich DI, Nagaraj S.

Nat Rev Immunol. 2009 Mar;9(3):162-74. doi: 10.1038/nri2506. Review.

Supplemental Content

Support Center